Medicare Part D coverage · berdazimer · RxCUI 2710443
berdazimer 0.103 MG/MG Topical Gel [Zelsuvmi]
Per the CMS 2026 Part D formulary file, berdazimer 0.103 MG/MG Topical Gel [Zelsuvmi] is covered by 227 Medicare Part D plans (4.5% of enrollable products), averaging Tier 4.1, with prior authorization required on 90% of covering formularies.
- 4.5%
- Plan coverage
- 227
- Plans covering
- T4.1
- Avg tier
- 90%
- Prior auth required
What the CMS Formulary Data Shows for berdazimer 0.103 MG/MG Topical Gel [Zelsuvmi]
Per the CMS 2026 Part D formulary file, berdazimer 0.103 MG/MG Topical Gel [Zelsuvmi] (RxNorm concept RXCUI 2710443, generic name berdazimer) appears on 20 distinct formulary files spanning 227 Medicare Part D plan offerings - 4.5% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 4.1.
Real-world access to berdazimer 0.103 MG/MG Topical Gel [Zelsuvmi] depends on utilization management as much as tier placement: 90% of covering formularies require prior authorization. 0% require step therapy. 85% apply quantity limits.
Medicare Part D spending dashboard figures are not published for this drug. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry berdazimer 0.103 MG/MG Topical Gel [Zelsuvmi] today.
Coverage Details
- Formularies covering
- 20
- Plans covering
- 227
- Coverage rate
- 4.5%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 90% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 85% of formularies
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering berdazimer 0.103 MG/MG Topical Gel [Zelsuvmi]
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Platino Blindao (HMO D-SNP) | Triple S Advantage, Inc. | T1 | Yes | $0 | PR |
| Platino Enlace (HMO D-SNP) | Triple S Advantage, Inc. | T1 | Yes | $0 | PR |
| Platino Advance (HMO D-snp) | Triple S Advantage, Inc. | T1 | Yes | $0 | PR |
| Platino Plus (HMO D-snp) | Triple S Advantage, Inc. | T1 | Yes | $0 | PR |
| Mass General Brigham SCO (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | Yes | $0 | MA |
| Mass General Brigham One Care (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | Yes | $0 | MA |
| CareAdvantage (HMO D-SNP) | SAN Mateo Health Commission | T2 | Yes | $0 | CA |
| CalOptima Health OneCare Complete (HMO D-SNP) | Orange County Health Authority | T2 | Yes | $0 | CA |
| Community Blue Medicare HMO Signature (HMO) | Highmark Western and Northeastern New York Inc. | T5 | Yes | $0 | NY |
| Community Blue Medicare HMO Merit (HMO) | Highmark Western and Northeastern New York Inc. | T5 | Yes | $0 | NY |
| Community Blue Medicare PPO Signature (PPO) | Highmark Senior Health Company | T5 | Yes | $0 | PA |
| Complete Blue PPO Signature (PPO) | Highmark Senior Health Company | T5 | Yes | $0 | PA |
| Community Blue Medicare Plus PPO Signature (PPO) | Highmark Senior Health Company | T5 | Yes | $0 | PA |
| Complete Blue PPO Signature (PPO) | Highmark Senior Health Company | T5 | Yes | $0 | PA |
| Complete Blue PPO Merit (PPO) | Highmark Senior Health Company | T5 | Yes | $0 | PA |
| Complete Blue PPO Signature (PPO) | Highmark Senior Health Company | T5 | Yes | $0 | PA |
| Complete Blue PPO Distinct (PPO) | Highmark Senior Health Company | T5 | Yes | $0 | PA |
| Community Blue Medicare Plus PPO Signature (PPO) | Highmark Senior Health Company | T5 | Yes | $0 | PA |
| Complete Blue Plus PPO Merit (PPO) | Highmark Senior Health Company | T5 | Yes | $0 | PA |
| Community Blue Medicare PPO Signature (PPO) | Highmark Senior Health Company | T5 | Yes | $0 | PA |
Show the next 30 plans
Showing top 50 of 100 plans.
Frequently Asked Questions
Is berdazimer 0.103 MG/MG Topical Gel [Zelsuvmi] covered by Medicare Part D?
Yes, berdazimer 0.103 MG/MG Topical Gel [Zelsuvmi] is covered by 227 Medicare Part D plans (4.5% of all Part D formularies).
What tier is berdazimer 0.103 MG/MG Topical Gel [Zelsuvmi] on Medicare Part D plans?
berdazimer 0.103 MG/MG Topical Gel [Zelsuvmi] averages Tier 4.1 across Part D plans, ranging from Tier 1 to Tier 5.
Does berdazimer 0.103 MG/MG Topical Gel [Zelsuvmi] require prior authorization?
90% of Part D formularies require prior authorization for berdazimer 0.103 MG/MG Topical Gel [Zelsuvmi]. Step therapy: 0%. Quantity limits: 85%.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
Similar prior-authorization rate
- 2500 MG testosterone 0.01 MG/MG Topical Gel 90% PA
- 5000 MG testosterone 0.01 MG/MG Topical Gel 90% PA
- 0.6 ML pegfilgrastim-fpgk 10 MG/ML Prefilled Syringe [Stimufend] 90% PA
- deferiprone 500 MG Oral Tablet 90% PA
- deferiprone 1000 MG Oral Tablet 90% PA
- 60 ACTUAT testosterone 20.25 MG/ACTUAT Topical Gel 89.9% PA